Table 1.
Different abundant taxa between Parkinson’s disease (PD) patients and healthy controls (HC).
| Phylum | Family | Genus | Increased Abundance | Decreased Abundance | References |
|---|---|---|---|---|---|
| Actinobacteria | 5 | 0 | [99,103,115,117,119] | ||
| Actinobacteria | Bifidobacteriaceae | 5 | 0 | [98,103,104,107,119] | |
| Actinobacteria | Bifidobacteriaceae | Bifidobacterium | 6 | 2 | [95,97,98,100,102,107,111,119] |
| Bacteroidetes | 2 | 5 | [95,97,99,101,104,109,119] | ||
| Bacteroidetes | Prevotellaceae | 0 | 5 | [24,60,97,105,109] | |
| Bacteroidetes | Prevotellaceae | Prevotella | 3 | 5 | [24,60,95,98,100,107,110,111] |
| Firmicutes | 3 | 4 | [60,101,103,104,113,115,117] | ||
| Firmicutes | Enterococcaceae | 3 | 1 | [96,97,99,106] | |
| Firmicutes | Lachnospiraceae | 0 | 9 | [98,101,103,104,106,107,117,118,119] | |
| Firmicutes | Lachnospiraceae | Roseburia | 0 | 10 | [98,101,103,106,107,111,114,117,118,119] |
| Firmicutes | Lachnospiraceae | Blautia | 0 | 6 | [95,98,99,101,111,119] |
| Firmicutes | Lactobacillaceae | 5 | 1 | [96,97,98,103,106,117] | |
| Firmicutes | Lactobacillaceae | Lactobacillus | 5 | 1 | [95,98,100,102,110,111] |
| Firmicutes | Ruminococcaceae | 3 | 2 | [24,98,99,109,117] | |
| Firmicutes | Ruminococcaceae | Faecalibacterium | 0 | 10 | [95,97,98,99,104,111,112,114,117,118] |
| Proteobacteria | 4 | 0 | [99,101,103,119] | ||
| Proteobacteria | Enterobacteriaceae | 6 | 0 | [24,97,99,103,104,106] | |
| Verrucomicrobia | 6 | 0 | [101,103,105,113,115,119] | ||
| Verrucomicrobia | Verrucomicrobiaceae | 8 | 0 | [60,98,101,103,105,106,109,119] | |
| Verrucomicrobia | Verrucomicrobiaceae | Akkermansia | 13 | 0 | [60,97,98,101,103,105,109,110,113,114,115,118,119] |
List of the most frequently found, at least in four independent cohorts, reported fecal microbiota alterations between PD patients and HC. Reported taxa are indicated in bold and higher taxonomic levels are provided when applicable. The number of publications reporting an increase or a decrease in the relative abundance in PD patients are indicated. Adapted from Boertien et al. [49].